Korean guidelines for pediatric procedural sedation Authors: Hye-Mi Lee, Young Sung Kim, Eun-Hee Kim, Jin-Tae Kim, Seyeon Park, Yong-Hee Park, Ji-Hoon Park, Jung-Woo Shim, Chung-Sik Oh, Young-Eun Jang, Sung-Ae Cho, Eun-Young Joo, Sang-Hwan Ji, Byung Gun Lim, Hyo-Jin Byon Published: 2026 ABSTRACT Safe and effective pediatric sedation depends on multiple factors, including the precise selection of sedative agents, provider expertise, availability of age-appropriate monitoring equipment, and the patients’ individual circumstances. These revised clinical practice guidelines, developed by the Korean Society of Pediatric Anesthesiologists, aim to promote safe and effective pediatric sedation across diverse clinical settings in Korea, thereby enhancing patient safety and standardizing care. These guidelines represent a comprehensive update to the first edition published in 2017, systematically revised through an expert consensus model to reflect the rapidly evolving clinical landscape. The revision prioritized clinical utility and consistency, incorporating the latest pharmacological and technological advancements, while optimizing the content for practical bedside use. Key recommendations cover the entire sedation continuum, including the identification of qualified providers, pre-sedation patient evaluation and fasting requirements, age-specific risk assessment, monitoring of the respiratory and cardiovascular systems, level of sedation, management of respiratory complications, and structured discharge criteria. These recommendations are intended to guide healthcare providers and guardians in sedation-related decision-making for various diagnostic and therapeutic procedures. Depending on the clinical needs and institutional limitations of the primary, secondary, and tertiary care facilities, sedation providers may apply these recommendations directly, adapt them to their specific environments, or use them as a foundational framework for internal protocols. INTRODUCTION Pediatric sedation is an essential clinical intervention designed to alleviate anxiety and distress in pediatric patients undergoing diagnostic or therapeutic procedures, thereby enhancing procedural success rates. Owing to their unique anatomical and physiological characteristics, children exhibit sedation responses and complication risks distinct from those of adults, necessitating a more precise and systematic approach. Although pediatric sedation is widely performed across various clinical settings in the Republic of Korea, standards of practice remain inconsistent, and sedation is sometimes administered without adequate standardized training or guidelines. To address these challenges, the Korean Society of Pediatric Anesthesiologists (KSPA) established the first edition of the “Pediatric sedation guidelines: a Korean perspective” in 2017. Since the publication of the first edition in 2017, the clinical landscape of pediatric sedation has rapidly evolved, with advancements in pharmacological options, monitoring equipment, and safety standards, alongside increasing national demand for enhanced patient safety. In response, the KSPA has revised the existing guidelines to reflect newly available evidence and changes in clinical practice since 2017. Compared with the prior version, key updates include (1) updated recommendations on pediatric fasting times and intra-sedation monitoring and (2) improved usability by reorganizing key content into tables and an algorithmic flowchart for easier implementation in clinical practice. This paper introduces the core components of the revised guidelines and proposes practical standards to enhance the safety and consistency of pediatric sedation in Korea. The Korean pediatric procedural sedation guidelines are available from the KSPA website (https://www.pedianesth.or.kr/board/list.html?code=docu03). METHODS Committee formation and scope To undertake this revision, the KSPA formed a Guideline Revision Committee comprising experts from the KSPA Academic Committee and key contributors to the first edition published in 2017. The scope encompasses minimal-to-deep sedation in pediatric and adolescent patients across all clinical settings outside the traditional operating suite. Revision process and principles The revision was conducted through a structured, practice-oriented process focused on clinical applications. The committee established the following core principles for the update: (1) Systematic consistency: Standardizing narrative styles and terminology across all sections to ensure a unified document. (2) Clinical accuracy: Identifying and correcting technical errors and outdated information from the first edition. (3) Field-oriented utility: Reorganizing content to prioritize ease of use for healthcare providers performing bedside sedation. (4) Resource optimization: Adjusting the depth of discussion based on clinical significance and reducing overlap with general anesthesia guidelines to focus specifically on pediatric sedation. (5) Evidence integration: Incorporating recent clinical updates and pharmacological advancements that have emerged since the initial publication. Consensus and validation Rather than relying solely on a formal Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach, which was limited by the lack of local randomized controlled trials for certain specific contexts, the development of these guidelines followed a structured expert consensus model and a rigorous multi-stage review process. Every member of the Guideline Revision Committee expressed their professional opinions on each section of the draft. A recommendation was considered approved and integrated into the guidelines only if a strong agreement (defined as at least 70% of the committee members in favor) was achieved. After the initial draft was prepared by the Revision Committee, it underwent a primary review by the Academic Committee of the KSPA, with subsequent revisions made based on their feedback. This was followed by a secondary review by the KSPA Board of Directors, where further refinements were integrated to finalize the clinical recommendations. To ensure the practical utility of the guidelines across diverse clinical settings, the committee sought external reviews from the Korean Society of Emergency Medicine and the Korean Society of Pediatric Emergency Medicine. These multidisciplinary perspectives were carefully evaluated and incorporated to enhance the applicability of the guidelines for non-anesthesiologist providers. PURPOSE These pediatric sedation guidelines, which reflect the current clinical status in the Republic of Korea, aim to provide healthcare providers with the necessary framework for delivering safe and effective sedation to children undergoing diagnostic and therapeutic examinations or procedures. The specific objectives are as follows: (1) To ensure patient safety during pediatric sedation. (2) To minimize physical discomfort and procedural pain. (3) To control anxiety and minimize psychological trauma by providing emotional support and pharmacological intervention. (4) To control behavior and movement, thereby facilitating the successful completion of diagnostic and therapeutic procedures. (5) To ensure safe discharge by adhering to appropriate and standardized criteria. DEFINITIONS Authorized sedation providers (1) Physicians performing and supervising pediatric sedation in clinical practice. (2) Physicians who have completed specialized training in sedation, cardiovascular interventions, and airway management. (3) Recommendation: For administering deep sedation, the procedure should be conducted by an anesthesiologist or a physician who is well versed in sedative pharmacology, proficient in airway management (including mask ventilation and endotracheal intubation), and certified in Pediatric Advanced Life Support or Korean Advanced Life Support. Sedation practitioners (1) Healthcare providers who administer medications, monitor vital signs during sedation, and provide recovery care. (2) Healthcare providers who have completed training in sedation, cardiovascular intervention, and airway management. (3) Recommendation: For sedation depths exceeding moderate levels, patients with American Society of Anesthesiologists (ASA) physical status III–IV, or those with anatomical airway abnormalities or risk of airway obstruction, additional personnel capable of advanced airway management should be involved. Target patients for sedation Pediatric patients undergoing diagnostic or therapeutic procedures under sedation. Levels of sedation Sedation exists along a continuum ranging from minimal to moderate sedation, deep sedation, and general anesthesia. The appropriate level of sedation must be planned based on the nature of the procedure and the patient’s condition. These levels are continuous, and as sedation deepens, the risk of respiratory and cardiovascular depression increases. These guidelines apply to the spectrum from minimal to deep sedation [1-6]. • Minimal sedation (anxiolysis): A drug-induced state during which patients respond normally to verbal commands. Respiratory and cardiovascular functions are unaffected. • Moderate sedation (conscious sedation): A drug-induced depression of consciousness during which patients respond purposefully to verbal commands. Spontaneous ventilation and cardiovascular function are typically maintained. • Deep sedation: A drug-induced state of depressed consciousness from which patients cannot be easily aroused but respond purposefully to repeated or painful stimulation. Spontaneous ventilation may be inadequate, and airway maintenance may be required, although cardiovascular function is usually maintained. • General anesthesia: A drug-induced loss of consciousness during which patients are not arousable, even with painful stimulation. This state often requires assistance in maintaining the airway and positive pressure ventilation; cardiovascular function may be impaired. Key terminology related to sedation (1) Sedation: A collective term for the act of reducing agitation and anxiety to facilitate diagnostic and therapeutic examinations and procedures. (2) Sedatives (sedative agents): A general term for pharmacological agents that produce sedative effects. (3) Monitoring: The continuous process of observing a patient’s status to collect clinical data, including both clinical observation (visual) and the use of medical devices. (4) Intervention: Any action taken to manage or improve a clinical situation, including procedures, medication administration, and various methods to stabilize the patient’s condition. APPLICATION Scope of application These guidelines apply to pediatric and adolescent patients undergoing minimal to deep sedation for diagnostic and therapeutic purposes. Clinical settings The guidelines are applicable in various settings, including: • Inpatient wards/outpatient clinics • Pediatric sedation units • Emergency departments • Operating rooms • Magnetic resonance imaging suites • Computed tomography suites • Electroencephalography rooms • Ultrasound rooms • Bone marrow aspiration/biopsy rooms • Endoscopy suites • Radiology suites and other diagnostic/interventional radiology procedure rooms. Clinical procedures (1) Pre-sedation evaluation and sedation planning (2) Obtaining informed consent (3) Administration of sedatives and intra-sedation monitoring (4) Post-sedation recovery and discharge Equipment (1) Oxygen source (2) Oxygen delivery and airway management tools: Age-appropriate equipment, including nasal cannulas, oxygen masks, oropharyngeal/nasopharyngeal airways, intubation equipment (endotracheal tubes, laryngoscopes, and laryngeal mask airways), and self-inflating bags (bag valve masks). (3) Vital signs monitor: (Refer to Section: ADMINISTRATION OF SEDATIVES AND INTRA-SEDATION MONITORING). (4) Electrocardiogram: Recommended for children with congenital anomalies or cardiovascular diseases, or during deep sedation. (5) Intravenous (IV) access equipment (6) Suction devices (7) Defibrillator and emergency cart PRE-SEDATION EVALUATION AND SEDATION PLANNING Before sedation, a comprehensive assessment of the patient’s procedure-associated risks, including detailed medical history, must be conducted. The ASA physical status classification is used to categorize risks based on comorbid conditions, with higher grades indicating higher predicted risk. Responsible personnel A qualified healthcare provider with sedation credentials must perform a pre-sedation evaluation and complete the assessment form (Appendix 1) before initiating any level of sedation, including minimal sedation. Evaluation components (1) Diagnosis and procedure: Name of the diagnosis and planned examination/procedure. (2) Medical history: Relevant past medical history (sedation-related); cardiovascular, pulmonary, hepatic, renal, cerebrovascular, and endocrine diseases; recent upper respiratory infections; presence of obstructive sleep apnea or related symptoms (including snoring); presence of facial/oral/airway tumors; and obesity [4,5]. (3) Airway assessment: Dental status, congenital craniofacial anomalies (such as Pierre-Robin, Goldenhar, Treacher Collins, and Down syndrome), limited mouth opening, macroglossia, tonsillar hypertrophy, cervical spine disease, spinal cord injury, morbid obesity, and Mallampati Class IV (where only the hard palate is visible and the soft palate/tonsillar fossa is obscured) [4,5]. (4) Fasting status: Nothing by mouth (NPO) duration. (5) Current medications (6) Diagnostic test results Planning and preparation The level of sedation is planned based on the pre-sedation evaluation, and appropriate medications and equipment are prepared. (1) Level of sedation: Determined by considering the intensity of procedure-related pain, the need for patient cooperation, and procedure duration [6]. (2) IV access: Determine whether IV access is required. (3) Personnel assignments: • Minimal and moderate sedation: Conducted by a physician or nurse with sedation credentials. • Deep sedation: Must be conducted by a physician with sedation credentials proficient in airway management, emergency response, and the pharmacology of sedative agents. • Staffing: It is strongly recommended that additional monitoring personnel be included as the depth of sedation increases [1,7]. • Transition of care: As moderate sedation can transition to deep sedation at any time, sedation should be provided by a physician proficient in mask ventilation and endotracheal intubation. • Anesthesiology consultation: It is strongly recommended to consult the Department of Anesthesiology and Pain Medicine in cases of previous sedation failure, anticipated difficult airways, or ASA physical status ≥ III. Note: Sedation credentials are granted only to healthcare providers who have completed designated training in sedation, cardiovascular intervention, and airway management. Key considerations in pre-sedation risk assessment (1) Most pediatric sedation-related complications manifest as airway or respiratory complications. (2) Generally, the risk of complications increases with sedation depth. (3) In children with anticipated difficult airways (including craniofacial anomalies or tumors) or ASA physical status ≥ III, even minimal sedation can lead to life-threatening situations. (4) Failure to adhere to sedation guidelines, such as inadequate monitoring or insufficient equipment, is a common contributor to poor outcomes when complications occur. (5) Adverse drug-related events are more frequently caused by dosing errors or inappropriate drug combinations rather than a specific drug or administration route. (6) Young age and obesity significantly increase the risk of sedation-related complications. OBTAINING INFORMED CONSENT This guideline provides templates for informed consent and explanatory documents that can be adapted for use in individual healthcare institutions (Appendix 2). Patient/guardian explanation and consent Before sedation, formal informed consent must be obtained after explaining the necessity, efficacy, benefits of sedation, potential alternatives, and any additional risks specific to the patient’s clinical condition. Required components of the consent form The sedation consent form must include the following items: (1) Patient status: Diagnosis, planned examination or procedure, key diagnostic results, and relevant clinical findings. (2) Purpose and benefits of sedation (3) Risks and potential complications of sedation (see also Section: RISKS AND COMPLICATIONS) (4) Alternative therapies available (5) Sedation process and medications to be used (6) Necessity of fasting: Importance of NPO status and potential complications (such as aspiration) that may occur if fasting requirements are not met. ADMINISTRATION OF SEDATIVES AND INTRA-SEDATION MONITORING This guideline provides templates for sedation and recovery records that can be adapted for use by individual healthcare institutions (Appendix 3). Selection of sedatives (see Supplementary Data 1) The selection of sedatives is based on the required sedation depth, planned procedure, and patient’s clinical status. The type, dosage, and route of administration are determined by a certified physician. Examples of commonly used agents include: (1) Sedative‒hypnotics: Chloral hydrate, midazolam, ketamine, propofol, and dexmedetomidine. (2) Opioid analgesics: Meperidine, fentanyl, and remifentanil (3) Antagonists (reversal agents): Naloxone and flumazenil Administration of sedative agents (1) Verify the patient’s diagnosis and planned surgery or procedure. (2) Confirm the presence of a signed informed consent for sedation. (3) Administer medications under the supervision of a certified physician. (4) Document the dosage and time of administration in the sedation record (Appendix 3). Monitoring (1) Monitoring parameters: • Blood pressure • Heart rate • Respiratory rate • End-tidal CO2 (ETCO2): Monitoring of ETCO2 via capnography is strongly recommended during moderate sedation and is mandatory during deep sedation. • Oxygen saturation (SpO2): Mandatory for all levels of sedation. • Sedation scale • Pain scale (as applicable, depending on the procedure and patient condition) [7] (2) Frequency of monitoring: • Vital signs must be recorded before and after drug administration, and upon completion of the procedure. SpO2 should be continuously monitored during sedation. • During the procedure, monitoring should be performed at the following intervals: - Minimal sedation: Every 15 min. - Moderate and deep sedation: At least every 5 min. • The frequency of measurement of each parameter may be adjusted during sedation based on the patient’s clinical condition (Table 1). POST-SEDATION RECOVERY AND DISCHARGE This guideline provides templates for sedation and recovery records that can be adapted for use by individual healthcare institutions (Appendix 3). Recovery room monitoring (1) Parameters: Monitoring parameters are identical to those used for sedation. (2) Frequency: Monitoring should be performed every 10 min from the beginning until the completion of the recovery process [1,2,4]. (3) Use of antagonists (reversal agents): • Routine or universal use of reversal agents should be avoided. • Antagonists should be administered and documented in the medical record if the patient exhibits inadequate spontaneous respiratory effort or at the discretion of an authorized sedation provider (see Supplementary Data 1). Discharge (1) Discharge criteria: Patients may be discharged under the direction of the responsible physician at least 30 min after the start of recovery, provided they achieve a (Modified) Aldrete Score of ≥ 9. • However, even if the total recovery score is < 9, patients may be discharged at the physician’s discretion if the sub-scores for respiration, circulation, and oxygen saturation are ≥ 2 points [4]. (2) Patient and guardian education: At the time of discharge, both verbal and written instructions must be provided to patients and their guardians. This education should cover potential complications, symptoms requiring attention, emergency response protocols, follow-up contact information, and general precautions (Appendix 4). RISKS AND COMPLICATIONS ① Respiratory system: Hypoxia, pulmonary aspiration, and airway obstruction. ② Cardiovascular system: Hypotension, arrhythmias, and cardiopulmonary collapse. ③ Unplanned admission: Unexpected hospitalization resulting from sedation- or procedure-related complications. ④ Procedural failure: Inability to complete the procedure due to inadequate depth of sedation (such as patient movement or agitation). ⑤ Adverse drug reactions: Side effects or idiosyncratic reactions associated with the administered sedative agents. ⑥ Others: Hypothermia, unintended awareness/arousal, physical injury related to patient positioning, and anaphylaxis (hypersensitivity reaction). GUIDELINES FOR SPECIAL SITUATIONS Specific guidelines must be followed for patients in special circumstances, such as children with disabilities, or in cases where difficulties in airway and cardiovascular management are anticipated. • (Refer to Supplementary Data 2) PEDIATRIC SEDATION FLOWCHART WITH ALGORITHM An overview of the pediatric sedation guideline is presented as a flowchart (Fig. 1).